Home › Gastrointestinal Cancers › Texas › Houston
Gastrointestinal Cancers clinical trials in Houston, TX
21 studies for Gastrointestinal Cancers are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
RecruitingPhase 1/2
- GSK Investigational Site, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- and 7 more
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Houston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- MD Anderson, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Recruiting
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Telephone Support in Advanced Gastrointestinal Cancer
Recruiting
- MD Anderson Cancer Center, Houston
Improving Comprehensive Care of Cancer Patients
RecruitingHealthy volunteers welcome
- Baylor College of Medicine, Houston
BOLSTER: Learning New Skills to Thrive
Recruiting
- The University of Texas MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecruitingPhase 1
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
RecruitingObservational study
- M D Anderson Cancer Center, Houston
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Recruiting
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Traction vs. No Traction in Colonic ESD
Recruiting
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Gastrointestinal Cancers trials in other cities
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN11 studies
- Los Angeles, CA10 studies
- Arlington, VA8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Dallas, TX8 studies
- Baldwin Park, CA7 studies
- Cincinnati, OH7 studies
- Seattle, WA7 studies
- Aurora, CO7 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.